Skip to main content
    G

    Greenwich Lifesciences Inc (GLSI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.76
    -1.18 (-7.90%)

    Market Cap: $219.29M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Greenwich Lifesciences Inc (GLSI) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Greenwich Lifesciences (GLSI) to earn -$1.39 per share in the fiscal year ending Dec 31, 2026. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.17.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$1.39
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$1.17
    EPS consensus
    Next report
    Jun 2, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$1.39-$1.48 to -$1.292
    Dec 31, 2027-$1.17-$1.17 to -$1.171

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.36-$0.39 to -$0.324

    Estimate Revisions

    No EPS estimate for the 2 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.35.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$1.39-$1.48-$1.48-$1.35-$1.35N/A

    Frequently Asked Questions About GLSI

    What is the GLSI stock forecast?

    Consensus analyst estimates put Greenwich Lifesciences's EPS at -$1.39 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from GLSI next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.39, with estimates from -$1.48 to -$1.29 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.17, with estimates from -$1.17 to -$1.17 from 1 analyst.

    How many analysts cover GLSI?

    2 analysts estimate EPS for Greenwich Lifesciences for the fiscal year ending Dec 31, 2026.